Podcasts about critical care division

June 16, 2022 ~ In this edition of "Michigan Answers" Paul talks to the Associate Professor of Internal Medicine, Pulmonary and Critical Care Division at Michigan Medicine about military burn pits and how they can affect veterans.

"Moral Injury: Losing Ourselves in the Pandemic Aftermath," by Daniel Garros, MD, Clinical Professor of Pediatrics, Critical Care Division, University of Alberta, Edmonton, Alberta, Canada. From ASRA News, August 2021. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.  

Our guest today is Dr. Charles Hardin of the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital.  He is an active contributor to FLARE (Fast Literature Assessment and Review), a collaborative effort within the Pulmonary and Critical Care Division and the Department of Medicine. The mission of FLARE is to appraise rapidly evolving literature on SARS-CoV-2.  Check FLARE out here: https://www.massgeneral.org/news/coronavirus/treatment-guidance/fast-literature-updates Connect with us @DepthAnesthesia on Twitter or email us at depthofanesthesia@gmail.com Thanks for listening! Please rate us on iTunes and share with your colleagues.  Music by Stephen Campbell, MD.  -- Full references on Episode Webpage.  https://us19.campaign-archive.com/?u=ef98149bee3f299584374540a&id=48d2c0484f

We investigate the claim that norepinephrine is not safe for peripheral administration. Our guests today are Dr. Katarina Ruscic and Dr. Jamie Sparling of the Critical Care Division of the Massachusetts General Hospital.  Full show notes available at depthofanesthesia.com.  Connect with us @DepthAnesthesia on Twitter or depthofanesthesia@gmail.com. Thanks for listening! Please rate us on iTunes and share with your colleagues.  Music by Stephen Campbell, MD.  -- References Cardenas‐Garcia J, Schaub KF, Belchikov YG, Narasimhan M, Koenig SJ, Mayo PH, Peripheral Administration of VM. J. Hosp. Med 2015;9;581-585. doi:10.1002/jhm.2394 Hasanin AM, Amin SA, Agiza NA, Elsayed MK, Refaa S, Hussein HA, Rouk TI, Alrahmany M. Elsayad M. Norepinephrine Infusion for Preventing Postspinal Anesthesia Hypotension during Cesarean Delivery Anesthesiology 2019; 130:55–62. Medlej K, Kazzi AA, El Hajj Chehade A. Complications from Administration of Vasopressors Through Peripheral Venous Catheters: An Observational Study. The Journal of emergency medicine. 2018; 54(1):47-53. Ngan Kee, WD A random-allocation graded dose-response study of norepinephrine and phenylephrine for treating hypotension during spinal anesthesia for cesarean delivery. Anesthesiology 2017; 127:934-41 Ngan Kee WD, Lee SWY, Ng FF, Khaw KS. Prophylactic norepinephrine infusion for preventing hypotension during spinal anesthesia for cesarean delivery. Anesth Analg. 2018;126:1989–1994. Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial. Am J Respir Crit Care Med. 2019 Parienti JJ, Mongardon N, Mégarbane B. Intravascular Complications of Central Venous Catheterization by Insertion Site. The New England journal of medicine. 2015; 373(13):1220-9. Ricard J, Salomon L, Boyer A, et al. Central or peripheral catheters for initial venous access of ICU patients. Crit Care Med 2013;41(9):2108-2115. --

We investigate the claim that administering ketorolac (Toradol) increases bleeding and should be avoided in surgeries for which there is concern for bleeding.  Claim 1. Administration of intraoperative ketorolac increases the bleeding time due to platelet inhibition Claim 2. Increased bleeding time translates to higher rate of surgical bleeding Claim 3. The magnitude of bleeding propensity attributable to ketorolac is clinically relevant Our guest today is Dr. Jamie Sparling of the Critical Care Division of the Massachusetts General Hospital.  Full show notes available at depthofanesthesia.com.  Connect with us @DepthAnesthesia on Twitter or depthofanesthesia@gmail.com. Thanks for listening! Please rate us on iTunes and share with your colleagues.  Music by Stephen Campbell, MD.  -- References Bailey R, Sinha C, Burgess LP. Ketorolac tromethamine and hemorrhage in tonsillectomy: A prospective, randomized, double-blind study. Laryngoscope 1997;107:166–169. Cassinelli EH, Dean CL, Garcia RM, Furey CG, Bohlman HH. Ketorolac use for postoperative pain management fol- lowing lumbar decompression surgery: A prospective, ran- domized, double-blinded, placebo-controlled trial. Spine (Phila Pa 1976) 2008;33:1313–1317. Gobble RM, Hoang HL, Kachniarz B, Orgill DP. Ketorolac does not increase perioperative bleeding: a meta-analysis of randomized controlled trials. Plastic and Reconstructive Surgery 2014; 133(3): 741-755 Singer AJ, Mynster CJ, McMahon BJ. The effect of IM ketoro- lac tromethamine on bleeding time: A prospective, interven- tional, controlled study. Am J Emerg Med. 2003;21:441–443. Strom BL, Berlin JA, Kinman JL, et al. Parenteral ketoro- lac and risk of gastrointestinal and operative site bleed- ing: A postmarketing surveillance study. JAMA 1996;275: 376–382.   --

This week we Flashback to one of our more popular shows with Christine Oliver, MD. Dr. Oliver joined us to discuss Odors and Chemical Sensitivities about 2 years ago. This was prior to our first YouTube videos so we are going to add some graphics and photos this week. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine. Dr. Oliver's primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks.    For the past three decades an important focus of Dr. Oliver's consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver's clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works.

This week we Flashback to one of our more popular shows with Christine Oliver, MD. Dr. Oliver joined us to discuss Odors and Chemical Sensitivities about 2 years ago. This was prior to our first YouTube videos so we are going to add some graphics and photos this week. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine. Dr. Oliver’s primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks. For the past three decades an important focus of Dr. Oliver’s consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver’s clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works.

Dr. Scott Manaker is an actively practicing pulmonary and critical care physician in the Pulmonary and Critical Care Division at the University of Pennsylvania in Philadelphia, where he is also Associate Professor of Medicine and Pharmacology, Vice Chair for Regulatory Affairs for the Department of Medicine and the Physician Advisor to the Penn Medicine Office of Billing Compliance. Dr. Manaker lectures widely across the United States as a physician advocate, speaking on chart documentation, coding, billing and reimbursement topics including the teaching physician regulations, critical care, evaluation and management coding, consultation policies, non-physician providers, and the impact of electronic medical records. In this episode, Dr. Manaker discusses the new and revised ICD-10-CM codes, which creates a marked difference for the world of PH. Learn more about the new codes at: www.phaware.global/ICD10. Learn more about pulmonary hypertension at phaware365.global. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD

This week we welcome Christine Oliver, MD to the show. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine, Dr. Oliver's primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks. For the past three decades an important focus of Dr. Oliver's consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver's clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works

This week we welcome Christine Oliver, MD to the show. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine, Dr. Oliver's primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks. For the past three decades an important focus of Dr. Oliver's consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver's clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works

Dr. Elliot Israel is a Professor of Medicine at Harvard Medical School and the Director of Clinical Research in the Pulmonary and Critical Care Division at Brigham and Women's Hospital, both in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Supplement to: Chowdhury B et al. The Risks and Benefits of Indracaterol - The FDA's Review. N Engl J Med 2011;365:2247-9.